Nucleic acid-based therapies for people with cystic fibrosis
OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of nucleic acid-based therapies in people with CF of any age and any genotype.
Authors
- Andrew Prayle (ORCID: https://orcid.org/0000-0002-1514-2840)
- Nikki Jahnke (ORCID: https://orcid.org/0000-0001-7836-0151)
- C. Addy (ORCID: https://orcid.org/0000-0002-4207-4409)
- Sherie Smith (ORCID: https://orcid.org/0000-0002-4143-5364)
- Cochrane Cystic Fibrosis
- Nikolas Johl (ORCID: https://orcid.org/0009-0008-9468-0268)
Institutions
- Cardiff and Vale University Health Board (GB)
- University of Nottingham (GB)
- Nottingham Biomedical Research Centre (GB)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2026-07-23
- DOI
- https://doi.org/10.1002/14651858.cd016370
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00